Polyamyna Nanotech Inc.
Transparent microbicidal coating with 7-day residual antimicrobial effect
- Sector
- Materials
- Headquarters
- ST. JOHN'S, A4
- Latest Form D
- $354K, Sep 2023
- Total capital
- $354K
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $354K
- 1 Form D · last Sep 2023
- 38 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 4 pending · first 2026
- Rank in peer group#83 of 369
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$354K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 369 peers
Line = medianMaterials · Material
- Granted patents#83 · top 22%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Ramesh Kumar ManiResearcherExecutive Officer, DirectorLinked by 1 patent
- Bala Kishan GorityalaExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 5- GrantedClear Coating Antimicrobial Compositions, Methods Of Preparation, And Uses Thereof For Conferring Antimicrobial Activity To A SurfaceUSPTOUS 12,662,601
- PendingAntimicrobial Nanoclays Comprising Cationic Antimicrobials, Method Of Preparation And Uses ThereofUSPTOApplication 19431063
- PendingShort Proline Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug- and Extensively Drug-Resistant Pseudomonas AeruginosaUSPTOApplication 18178143
Show all 5 patent records
- Clear Coating Antimicrobial Compositions, Methods Of Preparation, And Uses Thereof For Conferring Antimicrobial Activity To A SurfaceJun 23, 2026 · US 12,662,601Granted
- Antimicrobial Nanoclays Comprising Cationic Antimicrobials, Method Of Preparation And Uses ThereofMay 28, 2026 · Application 19431063Pending
- Short Proline Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug- and Extensively Drug-Resistant Pseudomonas AeruginosaSep 21, 2023 · Application 18178143Pending
- Antimicrobial Nanoclays Comprising Cationic Antimicrobials, Method Of Preparation And Uses ThereofAug 11, 2022 · Application 17611234Pending
- Short Proline-Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug-and Extensively Drug-Resistant Pseudomonas AeruginosaDec 31, 2020 · Application 16975791Pending
Related companies, and why
- Nvirovate Materials Inc.Similar federal contract value in Materials · null in contracts
- Delta Wing Project 56, LLCSimilar federal contract value in Materials · null in contracts
- IronTech Resources, LLCSimilar federal contract value in Materials · null in contracts
- Next Graphite, Inc.Similar federal contract value in Materials · null in contracts
- Modern Mining Ltd.Similar federal contract value in Materials · null in contracts
- Rainbow Rare Earths LtdSimilar federal contract value in Materials · null in contracts
Regulatory activity · Materials
- Eliminating Regulations Establishing Fellowships in Laboratory Standardization and Testing for Foreign CitizensNational Institute of Standards and Technology
- Eliminating Obsolete Marking Requirements for Toy, Look-Alike, and Imitation FirearmsNational Institute of Standards and Technology
- Eliminating Obsolete Regulations Related to the Advanced Technology Program and the Technology Innovation ProgramNational Institute of Standards and Technology
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .